Details of the Drug

General Information of Drug (ID: DMW6JJN)

• Drug Name: BreMel/TNF alpha
• Synonyms: BreMel/TNF alpha (melanoma/lobular breast cancer); Aka scFvMel/TNF (melanoma/lobular breast cancer), Targa Therapeutics; BreMel/TNF alpha (melanoma/ breast cancer), Targa Therapeutics; BreMel/TNF alpha (melanoma/lobular breast cancer), Targa Therapeutics; ScFvMel/TNF alpha (melanoma/ breast cancer), Targa Therapeutics; BreMel/TNF-a (melanoma/lobular breast cancer), Targa Therapeutics; ScFvMel/TNF-a (melanoma/lobular breast cancer), Targa Therapeutics; ZME-018 antibody fragment/TNF alpha (melanoma/ breast cancer), Targa Therapeutics

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Investigative	[1]

• Cross-matching ID: TTD ID: D07YPP

References

• [1] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.